🔗 Permalink

Inventor profile of:

Sajeev Chandran

City:

Pune

Country:

India

Published Applications:

Last publication date:

2024-10-24

Top Assignees for applications by Sajeev Chandran

The entities that hold a legal rights for patent applications filed by inventor Chandran Sajeev:

LUPIN LIMITED 6 Mumbai, Maharashtra, India
LUPIN LIMITED 4 Mumbai, India
Lupin Atlantis Holdings SA 4 Zug, Switzerland
LUPIN LIMITED 2 Mumbai, State of Maharashtra, India
Medicis Pharmaceutical Corporation 1 Scottsdale, AZ United States
LUPIN LIMITED 1 Maharashtra, India

Recent patent applications by Chandran Sajeev

Sajeev Chandran from Pune, IN has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-10-24

US20240350480A1

Human necessities

STABLE PHARMACEUTICAL COMPOSITION OF METHYLNALTREXONE FOR AN ORAL ADMINISTRATION

#2 | 2024-05-30

US20240173272A1

Human necessities

EXTENDED-RELEASE LIQUID COMPOSITIONS OF MEXILETINE FOR ORAL ADMINISTRATION

#3 | 2020-06-04

US20200171124A1

Human necessities

TOPICAL COMPOSITIONS FOR OPHTHALMIC AND OTIC USE

#4 | 2018-05-03

US20180116953A1

Human necessities

ORAL PHARMACEUTICAL COMPOSITION OF METHYLERGONOVINE AND METHODS OF USE THEREOF

#5 | 2018-05-03

US20180116952A1

Human necessities

ORAL PHARMACEUTICAL COMPOSITION OF METHYLERGONOVINE AND METHODS OF USE THEREOF

#6 | 2018-04-12

US20180098982A1

Human necessities

ORAL PHARMACEUTICAL COMPOSITION OF METHYLERGONOVINE AND METHODS OF USE THEREOF

#7 | 2018-04-12

US20180098942A1

Human necessities

ORAL PHARMACEUTICAL COMPOSITION OF METHYLERGONOVINE AND METHODS OF USE THEREOF

#8 | 2017-02-02

US20170027863A1

Human necessities

Oral controlled release pharmaceutical compositions of Bepotastine

#9 | 2015-06-04

US20150150809A1

Human necessities

Immediate Release Compositions and Methods For Delivering Drug Formulations Using Weak Acid Ion Exchange Resins In Abnormally High pH Environments

#10 | 2015-01-15

US20150017242A1

Human necessities

Bilayer Tablet of Dronedarone

#11 | 2014-09-18

US20140274970A1

Human necessities

Controlled release pharmaceutical dosage forms

#12 | 2013-12-05

US20130323309A1

Human necessities

Sustained Release Composition of Memantine

#13 | 2013-11-28

US20130317063A1

Human necessities

Oral controlled release pharmaceutical compositions of bepotastine

#14 | 2013-08-08

US20130203721A1

Human necessities

TASTE-MASKED POWDER FOR SUSPENSION COMPOSITIONS OF METHYLPREDNISOLONE

#15 | 2013-06-06

US20130143897A1

Human necessities

ORAL CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS OF BLONANSERIN

#16 | 2013-06-06

US20130142849A1

Human necessities

CONTROLLED RELEASE FORMULATIONS OF DRONEDARONE

#17 | 2013-01-24

US20130022654A1

Human necessities

Controlled release pharmaceutical compositions of tapentadol

#18 | 2013-01-03

US20130004545A1

Human necessities

SLOW RELEASE PHARMACEUTICAL COMPOSITIONS OF ILOPERIDONE

#19 | 2012-11-08

US20120283252A1

Human necessities

Process for preparing pharmaceutical ophthalmic compositions

#20 | 2012-02-02

US20120027855A1

Human necessities

PHARMACEUTICAL COMPOSITIONS FOR GASTROINTESTINAL DRUG DELIVERY

InventorID:

10787 ⎘